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Rare sarcomatoid carcinoma of the liver in a patient with no history of 
hepatocellular carcinoma: a case report 
 
Abstract 
Sarcomatoid carcinoma is a rare malignant tumor of unknown pathogenesis characterized by 
poorly differentiated carcinoma tissue containing sarcoma-like differentiation of either spindle or 
giant cell and rarely occurs in the gastrointestinal tract and hepatobiliary-pancreatic system.1   
Primary hepatic sarcomatoid carcinoma accounts for only 0.2 % of primary malignant liver 
tumors, and 1.8% of all surgically resected hepatocellular carcinomas.2  The majority of hepatic 
sarcomatoid carcinoma cases appear to occur simultaneously with hepatocellular or 
cholangiocellular carcinoma.3  The preferred treatment for hepatic sarcomatoid carcinoma is 
surgical resection and the overall prognosis is poor.4   This case depicts a 62-year-old female 
who underwent initial resection of a cavernous hemangioma in 2010.  Seven years after her 
initial diagnosis, she developed what was initially felt to be local recurrence of the hemangioma 
but additional diagnostic workup with a liver biopsy confirmed primary hepatic sarcomatoid 
carcinoma. 
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Case Report 
 
A 62-year-old female with past medical history significant for vegan diet, hypothyroidism, iron 
deficiency anemia, and cavernous liver hemangioma presented with weight loss and abdominal 
fullness for approximately one month with two days of acute altered mental status, fatigue, and 
weakness.    
 
Patient had a complicated gastrointestinal history and underwent surgical resection of a 
cavernous hemangioma in 2010.  Six years later, she developed abdominal fullness with right 
upper quadrant pain and an abdominal ultrasound at that time suggested hemangioma recurrence.   
In 2017, she underwent laparoscopy with unroofing of the hemangioma, drainage of an old 
organizing hematoma, removal of debris, and placement of an omental patch.  Patient developed 
subsequent abdominal ventral hernia but a scheduled repair in January of 2018 was deferred due 
new onset of iron deficiency anemia with a hemoglobin of 6.7 g/dL.  She underwent EGD and 
colonoscopy which revealed candida esophagitis and diverticulosis but no identifiable bleeding 
source.  Her acute anemia was attributed to a nutritional deficit from her vegan diet so ferrous 
sulfate 325 mg tablets three times a day were started.  Abdominal CT scan showed a 13.6 cm 
mass adjacent to the gallbladder fossa, but further workup was deferred due to her anemia.  In 
February, the patient’s anemia persisted despite oral iron replacement therapy and she received 
infusion of feraheme 510 mg. She underwent subsequent EGD for reevaluation of anemia and 
repair of periumbilical hernia during the same month.  In March, she was admitted for abnormal 
PET scan concerning for liver malignancy with maximum SUV of 20.1 g/mL.  Liver abscess was 
diagnosed and CT guided drainage was performed. She was treated with amoxicillin/clavulanate 
and discharged home.   
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 Three weeks later, she returned with abdominal pain, fatigue, poor appetite, intermittent fevers, 
altered mental status, and diarrhea. On examination, patient appeared uncomfortable, pale, and 
weak. Her medications included armour thyroid, ranitidine, and amoxicillin/clavulanate.   Vitals 
included: pulse rate 127, blood pressure 108/56, temperature 101.8, respiratory rate 20 and 
oxygen saturations of 98 % on room air.  Patient appeared drowsy but cooperative and not in 
distress.  HEENT: normocephalic, pupils equal, round and reactive to light, extraocular 
movement intact.  Respiratory: tachypneic with non-labored respirations and decreased breath 
sounds bilaterally.  Cardiovacular: tachycardic with normal rhythm.  Gastrointestinal: soft, non-
tender, non-distended, normal bowel sounds.  Surgical incision sites were healing. Skin: warm, 
dry, pink with +2 pitting bilateral lower extremity edema.  
 
Diagnostic data demonstrated leukocytosis of 15 g/dL, hemoglobin of 6.0 g/dL, albumin of 1.5 
g/dL, and normal liver enzymes with mildly elevated bilirubin level of 1.2 mg/dL.  CT scan of 
abdomen showed large heterogeneous lobular mass measuring 14.6 cm x 10.8 cm in the superior 
portion of the right liver lobe with an inferior calcified cystic mass measuring 6.5 cm x 5.3 cm. 
Acute hepatitis panel, serum alpha-feto protein, carcinomembryonic antigen, and CA-19-9 were 
negative. Patient started on vancomycin and piperacillin/tazobactam, and transfused two units of 
PRBCs.  Gastrointestinal PCR panel was positive for enteropathic Escherichia coli and 
Clostridium difficile so oral vancomycin was initiated.  Additional anemia workup including 
bone marrow biopsy, EGD, and tagged RBC scan did not reveal source of anemia. CT 
enterography (Figure 1) showed large liver mass with liquefaction and air in inferior portion and 
a small tract of fluid between the mass and duodenal bulb concerning for fistulous tract.   
 
 
 
 
Figure 1: Large liver mass 
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Diagnosis of hepatic sarcomatoid carcinoma was obtained by liver biopsy with gross specimen 
demonstrating spindle shaped cells (Figures 2-4). 1,5,6,7  Immunohistochemical panel additionally 
confirmed sarcomatoid carcinoma given expression of multiple cytokeratin (CAM 5.2, 
cytokeratin AE1/AE3, oscar cytokeratin) and lack of reactivity for other lineage specific markers 
(Melan-A and SOX10, SMA, ALK, ERG, Desmin, CD21, CD3, CD20, CD15, CD30, PAX5, 
CD45, CD5, and S100).  Sarcomatoid hepatocellular carcinoma and cholangiocarcinoma with 
sarcomatoid features were excluded as immunohistochemistry testing was negative for Hep Par-
1, Arginase, Albumin ISH. The patient was transferred to a liver center and ultimately pursued 
hospice due to poor prognosis and passed away a few weeks later.  
 
 
 
 
Figure 2: Low-power view predominantly showing a diffuse area of tumor with an area of 
benign liver with steatosis on the right side corner 
 
   
 
   
 
 
 
 
 
 
 
                                                      A                                                           B 
 
Figure 3:  A) Low-power view showing spindle growth pattern of tumor, B) High-power view 
showing spindle neoplastic cells with large cells 
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Figure 4: Immunohistochemical stains for multiple cytokeratins are positive for tumor – A) 
Oscar cytokeratin, B) CAMP5.2, and C) Pancytokeratin (AE1/AE3). 
 
Discussion 
 
Hepatic sarcomatoid carcinoma is a rare malignant neoplasm of unclear pathogenesis.  
Presenting symptoms of sarcomatoid carcinoma are similar to that of hepatoceullar carcinoma 
with abdominal pain, weight loss, anorexia, and fatigue, which was the case for our patient.  
Hepatic sarcomatoid has a high risk of relapse, venous and intrahepatic invasion, and distant and 
lymph node metastasis at time of diagnosis.   The preferred treatment for hepatic sarcomatoid 
carcinoma is surgical resection and the overall prognosis is poor.8  
 
The present study reports a rare case of hepatic sarcomatoid carcionoma in a patient with a 
previous cavernous hemangioma.  Previous studies have reported the usefulness of 
chemotherapy and literature review found one study with documentation of complete resolution 
of hepatic sarcomatoid carcinoma after seven cycles of doxorubicin and ifosfamide but no large-
sample studies exist.9   Efficacy of alternative treatments such as radiotherapy, chemotherapy, 
and targeted therapy are unclear. 
 
Liver conditions that have been associated with the development of liver sarcomatoid carcinoma 
include hepatitis C virus (HCV) and hepatocellular carcinoma (HCC).10 Though liver 
malignancy can also be secondary to a primary GI sarcoma it is a rare or unknown cause of liver 
sarcomatoid carcinoma.   In this particular case, the patient did not have a history of HCV, HCC 
or gastrointestinal malignancy.  Her presentation was confounded by a history of iron deficiency 
anemia, and development of a hepatic abscess after surgical intervention to un-roof a recurring 
cyst which turned out to be hematoma.  Cystic lesions of the liver are a common occurrence but 
rarely lead to primary liver neoplasms.  The diagnosis of hepatic sarcomatoid remains elusive 
due its vague symptomatology and rarity.  Additional studies are needed to explore possible 
adjunctive therapies to surgical resection to improve survival rates.   
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